1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Class Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Sector
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Denmark - Market size and forecast 2024-2029 ($ million)
- Data Table on Denmark - Market size and forecast 2024-2029 ($ million)
- Chart on Denmark: Year-over-year growth 2024-2029 (%)
- Data Table on Denmark: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Pharmaceutical Market in Denmark 2019 - 2023
- Historic Market Size - Data Table on Pharmaceutical Market in Denmark 2019 - 2023 ($ million)
- 5.2 Class Type segment analysis 2019 - 2023
- Historic Market Size - Class Type Segment 2019 - 2023 ($ million)
- 5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.4 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.5 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
- 5.6 Sector segment analysis 2019 - 2023
- Historic Market Size - Sector Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on pharmaceutical market in Denmark
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Class Type
- 8.1 Market segments
- Chart on Class Type - Market share 2024-2029 (%)
- Data Table on Class Type - Market share 2024-2029 (%)
- 8.2 Comparison by Class Type
- Chart on Comparison by Class Type
- Data Table on Comparison by Class Type
- 8.3 Musculoskeletal system - Market size and forecast 2024-2029
- Chart on Musculoskeletal system - Market size and forecast 2024-2029 ($ million)
- Data Table on Musculoskeletal system - Market size and forecast 2024-2029 ($ million)
- Chart on Musculoskeletal system - Year-over-year growth 2024-2029 (%)
- Data Table on Musculoskeletal system - Year-over-year growth 2024-2029 (%)
- 8.4 Nervous system - Market size and forecast 2024-2029
- Chart on Nervous system - Market size and forecast 2024-2029 ($ million)
- Data Table on Nervous system - Market size and forecast 2024-2029 ($ million)
- Chart on Nervous system - Year-over-year growth 2024-2029 (%)
- Data Table on Nervous system - Year-over-year growth 2024-2029 (%)
- 8.5 Respiratory system - Market size and forecast 2024-2029
- Chart on Respiratory system - Market size and forecast 2024-2029 ($ million)
- Data Table on Respiratory system - Market size and forecast 2024-2029 ($ million)
- Chart on Respiratory system - Year-over-year growth 2024-2029 (%)
- Data Table on Respiratory system - Year-over-year growth 2024-2029 (%)
- 8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Class Type
- Market opportunity by Class Type ($ million)
- Data Table on Market opportunity by Class Type ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 9.3 Offline - Market size and forecast 2024-2029
- Chart on Offline - Market size and forecast 2024-2029 ($ million)
- Data Table on Offline - Market size and forecast 2024-2029 ($ million)
- Chart on Offline - Year-over-year growth 2024-2029 (%)
- Data Table on Offline - Year-over-year growth 2024-2029 (%)
- 9.4 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 10.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 10.3 Prescription drugs - Market size and forecast 2024-2029
- Chart on Prescription drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Prescription drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Prescription drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Prescription drugs - Year-over-year growth 2024-2029 (%)
- 10.4 OTC drugs - Market size and forecast 2024-2029
- Chart on OTC drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on OTC drugs - Market size and forecast 2024-2029 ($ million)
- Chart on OTC drugs - Year-over-year growth 2024-2029 (%)
- Data Table on OTC drugs - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
11 Market Segmentation by Drug Class
- 11.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
- 11.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 11.3 Branded drugs - Market size and forecast 2024-2029
- Chart on Branded drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Branded drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Branded drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Branded drugs - Year-over-year growth 2024-2029 (%)
- 11.4 Generic drugs - Market size and forecast 2024-2029
- Chart on Generic drugs - Market size and forecast 2024-2029 ($ million)
- Data Table on Generic drugs - Market size and forecast 2024-2029 ($ million)
- Chart on Generic drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Generic drugs - Year-over-year growth 2024-2029 (%)
- 11.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
12 Market Segmentation by Sector
- 12.1 Market segments
- Chart on Sector - Market share 2024-2029 (%)
- Data Table on Sector - Market share 2024-2029 (%)
- 12.2 Comparison by Sector
- Chart on Comparison by Sector
- Data Table on Comparison by Sector
- 12.3 Primary sector - Market size and forecast 2024-2029
- Chart on Primary sector - Market size and forecast 2024-2029 ($ million)
- Data Table on Primary sector - Market size and forecast 2024-2029 ($ million)
- Chart on Primary sector - Year-over-year growth 2024-2029 (%)
- Data Table on Primary sector - Year-over-year growth 2024-2029 (%)
- 12.4 Hospital sector - Market size and forecast 2024-2029
- Chart on Hospital sector - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital sector - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital sector - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital sector - Year-over-year growth 2024-2029 (%)
- 12.5 Market opportunity by Sector
- Market opportunity by Sector ($ million)
- Data Table on Market opportunity by Sector ($ million)
13 Customer Landscape
- 13.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
14 Drivers, Challenges, and Opportunity/Restraints
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 ALK Abello AS
- ALK Abello AS - Overview
- ALK Abello AS - Product / Service
- ALK Abello AS - Key offerings
- SWOT
- 16.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 16.6 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.7 Ferring BV
- Ferring BV - Overview
- Ferring BV - Product / Service
- Ferring BV - Key news
- Ferring BV - Key offerings
- SWOT
- 16.8 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- 16.9 H Lundbeck AS
- H Lundbeck AS - Overview
- H Lundbeck AS - Product / Service
- H Lundbeck AS - Key offerings
- SWOT
- 16.10 LEO Pharma AS
- LEO Pharma AS - Overview
- LEO Pharma AS - Product / Service
- LEO Pharma AS - Key offerings
- SWOT
- 16.11 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
- 16.12 ORIFARM GROUP AS
- ORIFARM GROUP AS - Overview
- ORIFARM GROUP AS - Product / Service
- ORIFARM GROUP AS - Key offerings
- SWOT
- 16.13 Orion Corp.
- Orion Corp. - Overview
- Orion Corp. - Product / Service
- Orion Corp. - Key offerings
- SWOT
- 16.14 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 16.15 Sandoz Group AG
- Sandoz Group AG - Overview
- Sandoz Group AG - Product / Service
- Sandoz Group AG - Key offerings
- SWOT
- 16.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 16.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
- 16.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
17 Appendix
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
Get the report (PDF) sent to your email within minutes.